GlassScriptPhysician profile
Jennifer Mcbrayer
NPI 1932405891
$714.83
in general payments reported to CMS, 2019-2025
17 companies · $115 in 2025
The $115 reported for 2025 was more than what a typical Pediatrics (Nurse Practitioner) provider received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $321 · 2024: $279 · 2025: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $715.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $714.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $129.82 | 2023-2024 | |
| Vertical Pharmaceuticals, LLC | $97.43 | 2024 | Relexxii |
| Edwards Lifesciences Corporation | $84.79 | 2023-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Seqirus USA INC | $67.16 | 2023-2024 | Flucelvax, Fluad, Flucelvax Quadrivalent |
| Ironshore Pharmaceuticals INC. | $60.97 | 2023-2024 | Jornay Pm |
| Abbvie INC. | $47.47 | 2023 | |
| Medtronic, INC. | $37.30 | 2025 | Symplicity G3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.33 | 2023 | Synjardy, Tradjenta |
| Alexion Pharmaceuticals, INC. | $20.42 | 2023 | Strensiq |
| Amgen INC. | $20.14 | 2023 | Repatha |
| Ossur Americas, INC. | $19.28 | 2025 | |
| Cranial Technologies, INC | $19.14 | 2025 | Doc Band |
| Avion Pharmaceuticals | $18.89 | 2023 | Methylphenidate Hydrochloride |
| Hologic Sales and Service, LLC | $18.52 | 2025 | Aptima, Thinprep 2000 Processor |
| Pfizer INC. | $18.17 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $15.16 | 2023 | Austedo |
| Sanofi Pasteur INC. | $14.84 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Mcbrayer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.